TLR signaling inhibitor, phenylmethimazole, in combination with tamoxifen inhibits human breast cancer cell viability and migration-Reference-Cited by-同舟云学术

TLR signaling inhibitor, phenylmethimazole, in combination with tamoxifen inhibits human breast cancer cell viability and migration

Published:2016-07-01 Issue:69 Volume:8 Page:113295-113302
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Schwartz Anthony L.¹,Dickerson Eric²,Dagia Nilesh³,Malgor Ramiro²,McCall Kelly D.⁴

Affiliation:

1. Athencion Biotechnology Corporation, Suite 100, Marietta, OH 45750, USA

2. Department of Biomedical Sciences, Appalachian Rural Health Institute, Diabetes Research Center, College of Osteopathic Medicine, Ohio University, Athens, OH 45701, USA

3. Oxygen Healthcare Research Pvt. Ltd, Ahmedabad, Gujarat 382213, India

4. Department of Specialty Medicine, Appalachian Rural Health Institute, Diabetes Research Center, College of Osteopathic Medicine, Ohio University, Athens, OH 45701, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Editorial: Toll-like receptor expression in transformed cells: role in tumor development and cancer therapies;Frontiers in Immunology;2024-08-22

2. Anti-Inflammatory and Therapeutic Effects of a Novel Small-Molecule Inhibitor of Inflammation in a Male C57BL/6J Mouse Model of Obesity-Induced NAFLD/MAFLD;Journal of Inflammation Research;2023-11

3. Toll‑like receptor 3 ligands for breast cancer therapies (Review);Molecular and Clinical Oncology;2023-06-22

4. High expression of TLR3 in triple-negative breast cancer predicts better prognosis—data from the Fudan University Shanghai Cancer Center cohort and tissue microarrays;BMC Cancer;2023-04-01

Network Pharmacology-Oriented Identification of Key Proteins and Signaling Pathways Targeted by Xihuang Pill in the Treatment of Breast Cancer

;Breast Cancer: Targets and Therapy;2020-12